Loading clinical trials...
Loading clinical trials...
Evaluation of the Correlation Between the MS Functional Composite Index and Two Quality of Life Scales (MS54 and AMS Quality of Life) in Relapsing MS Patients Treated With Interferon Beta-1a (AVONEX®)
Conditions
Interventions
Interferon beta-1a
Locations
3
Belgium
Coordinating Research Site
Sijsele-Damme, Belgium
Coordinating Research Site
Esch-sur-Alzette, Luxembourg
Coordinating Research Site
Glasgow, Scotland, United Kingdom
Start Date
November 1, 1999
Completion Date
February 1, 2004
Last Updated
December 13, 2007
NCT04047628
NCT04602390
NCT05978531
NCT04225312
NCT03536559
NCT05446285
Lead Sponsor
Biogen
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions